Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab Treatment

NCT06931613 · clinicaltrials.gov ↗

PHASE2

Phase

ENROLLING_BY_INVITATION

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Relapsed or Refractory Hodgkin Lymphoma
Children
Nivolumab
Autologous Haemopoietic Stem Cell Transplant

Interventions

DRUG: Nivolumab

Sponsor

St. Petersburg State Pavlov Medical University